정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1374 | Not yet recruiting | Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer | Venlafaxine | Behavioral: Interpersonal Psychotherapy Drug: Venlafaxine HCl ER |
Phase 3 | New York State Psychiatric Institute, Columbia University | OTHER | 20 | All | 18 Years ~ 80 Years | |
| 1373 | Recruiting | Fenofibrate for Patients With COVID-19 Requiring Hospitalization | SARS-CoV-2 Infection | Drug: TriCor® 145mg tablets Other: Usual Care Other: Placebo |
Phase 3 | Hebrew University of Jerusalem, Barzilai Medical Center | OTHER | 50 | All | 18 Years ~ 85 Years | Barzilai Medical Center, Ashkelon, Israel |
| 1372 | Active, not recruiting | Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection | Acute Respiratory Distress Syndrome | Drug: Alteplase 50 MG [Activase] Drug: Alteplase 50 MG [Activase] |
Phase 2 | Denver Health and Hospital Authority, Genentech, Inc., University of Colorado, Denver, National Jewish Health, Beth Israel Deaconess Medical Center, Long Island Jewish Medical Center, Scripps Health, St. Mary's Medical Center, University of Miami, Ben Taub Hospital, Methodist Dallas Medical Center | OTHER | 50 | All | 18 Years ~ 75 Years | Scripps Memorial Hospital La Jolla, La Jolla, California, United States University of Colorado, Denver, Aurora, Colorado, United States Denver Health Medical Center, Denver, Colorado, United States National Jewish Health, Denver, Colorado, United States St. Mary's Medical Center, West Palm Beach, Florida, United States Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States Long Island Jewish Medical Center, New York, New York, United States Methodist Dallas Medical Center, Dallas, Texas, United States Ben Taub Hospital, Houston, Texas, United States |
| 1371 | Completed | Fight COVID-19 Trial | COVID-19 | Drug: Oral | Phase 3 | Rajavithi Hospital | OTHER_GOV | 320 | All | 16 Years ~ 100 Years | Assistant Professor Subsai Kongsaengdao, Bangkok, Thailand |
| 1370 | Recruiting | Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) | COVID-19 | Drug: Favipiravir Drug: Monoclonal antibodies Drug: Ivermectin Other: No treatment Drug: Remdesivir |
Phase 2 | University of Oxford | OTHER | 750 | All | 18 Years ~ 50 Years | Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand |
| 1369 | Withdrawn | Fingolimod in COVID-19 | Coronavirus Disease (COVID-19) | Drug: Fingolimod 0.5 mg | Phase 2 | First Affiliated Hospital of Fujian Medical University | OTHER | 0 | All | 18 Years ~ 80 Years | Wan-Jin Chen, Fuzhou, China |
| 1368 | Completed | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | Inflammatory Lung Conditions Associated With COVID-19 | Drug: TD-0903 Drug: Placebo |
Phase 1 | Theravance Biopharma | INDUSTRY | 54 | All | 18 Years ~ 50 Years | Theravance Biopharma Investigational Site, Manchester, United Kingdom |